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Objective:  Leukoplakia  is  the  most  common  potentially  malignant  disorder  preceding  oral  cancer.  Chemi-
luminescence  has  been  developed  as  an  adjunct  to  conventional  examination  for the  diagnosis  of  these
potentially  malignant  disorders.  This  study  was  conducted  to assess  the efﬁcacy  of  chemiluminescence
in  the diagnosis  of  leukoplakia  and  to compare  the results  with  histopathological  examination.
Study design:  A  total  of 50 patients  with  leukoplakia  were  included  from  the  outpatients  attending
the  Department  of  Oral Medicine  and  Radiology,  Dental  Hospital,  Bengaluru,  Karnataka,  India.  These
patients  were  subjected  to  conventional  oral  examination  followed  by  chemiluminescent  examination
with  Vizilite  (Zila,  Fort  Collins,  CO,  USA)  and  biopsy  for histopathological  conﬁrmation.eukoplakia
ral cancer
Results: The  sensitivity,  speciﬁcity,  positive  predictive  value,  and  negative  predictive  value  of
chemiluminescence  were  93.75%,  55.56%,  78.95%,  and  83.3%,  respectively.  The  overall  accuracy  of chemi-
luminescence  was  80%.  A  statistically  signiﬁcant  association  was  observed  between  histopathology
results  and  chemiluminescence  results.
Conclusion: Although  it is an  easy,  safe,  minimal  time  consuming,  and  noninvasive  technique,  it  has  only
adjunctive  utility  and  it does  not  replace  biopsy  for the  diagnosis  of  leukoplakia.
©  2014  Japanese  Stomatological  Society.  Published  by  Elsevier  Ltd. All rights  reserved.. Introduction
Oral cancer is the sixth most common malignancy around the
lobe [1]. The annual incidence [2] for oral cancer is around 275,000
ith India having the highest incidence rate of oral cancer world-
ide. Despite advances in cancer therapies, the 5-year survival
ate is just 50% [3]. This is due to detection of oral cancer at the
ymptomatic advanced stages. However, if diagnosed at an early
symptomatic stage, oral cancer is often curable and inexpensive
o treat. Therefore, the focus has now shifted toward the prevention
f oral cancer. Primary prevention including changing habits and
ifestyle are slow to implement. So, secondary prevention i.e. early
iagnosis and prompt treatment has become extremely important
or the oral health care professional.
The natural history of oral cancer also demonstrates that it is
receded by a precancerous stage in the form of potentially malig-
ant disorders (PMDs) [4]. The most common PMD  is leukoplakia.
he diagnosis of leukoplakia is mainly clinical. But clinical exam-
nation cannot distinguish between dysplastic and nondysplastic
eukoplakia.
∗ Corresponding  author at: House No. 617, 1st Floor, Sector 9, Gurgaon 122001,
aryana,  India. Tel.: +91 9711807733; fax: +91 124 2278151.
E-mail  address: dr.asthac@gmail.com (A. Chaudhry).
348-8643/$ – see front matter © 2014 Japanese Stomatological Society. Published by Els
ttp://dx.doi.org/10.1016/S1348-8643(14)00004-4For diagnosis of dysplasia, biopsy and histopathological exami-
nation has been the gold standard. But the invasiveness of scalpel
biopsy has urged the need for the development of noninvasive
adjunctive tools at both clinical and molecular level to assess the
oral lesions of uncertain biologic signiﬁcance. These include vital
staining, oral CDx brush biopsy (CDx Diagnostics, Suffern, NY, USA),
and visualization techniques.
The  visualization techniques are appurtenants to the standard
visual and tactile oral examination under incandescent light. They
function under the assumption that during carcinogenesis mucosal
tissues undergo abnormal metabolic or structural changes that
show different absorbing and reﬂecting properties when exposed
to various forms of light or energy [5]. Chemiluminescene (light
emission from chemical reaction) has been used previously to
detect cervical neoplasia [6,7]. Vizilite (Zila, Fort Collins, CO, USA)
is a recently introduced chemiluminescent technique that allows
the dysplastic areas i.e. cells with altered nuclear cytoplasmic ratio
to preferentially reﬂect the low energy blue white light emitted
by the device and appear aceto-white with brighter, sharper, and
distinct margins. It is an easy, safe, and non-invasive technique
[3].The aim of the study was  to assess the efﬁcacy of a commer-
cially available chemiluminescent kit (Vizilite) in the diagnosis of
leukoplakia and to compare the results with the histopathological
examination.
evier Ltd. All rights reserved.
nce International 11 (2014) 56–59 57
2
s
w
O
T
i
w
e
m
i
b
V
t
r
a
f
i
r
a
a
a
s
m
d
c
l
w
s
l
l
e
p
O
a
(
s
p
w
h
s
3
g
g
a
d
d
c
a
a
l
t
sA. Chaudhry, M. M / Oral Scie
. Materials and methods
A  total of 50 adult patients of either gender or any race pre-
enting with leukoplakia either homogenous or non-homogenous
ere selected from the outpatients attending the Department of
ral Medicine and Radiology, V.S. Dental Hospital, Bengaluru, India.
he study was approved by the institutional review board and eth-
cal clearance was obtained.
The procedure was explained to the patient and written consent
as obtained. Each patient underwent a conventional soft-tissue
xamination under incandescent light where the lesion size,
orphology, and texture were noted and documented photograph-
cally. This was followed by chemiluminescent examination and
iopsy by the same examiner.
For chemiluminescent examination, commercially available
izilite kit was used. It consisted of a Vizilite 1% acetic acid solu-
ion, a single-use chemiluminescent light stick, and a handheld
etractor to hold the activated light stick. The capsule comprised
n outer ﬂexible plastic containing acetyl salicylic acid and an inner
ragile glass vial containing hydrogen peroxide. When the capsule
s ﬂexed, the inner glass vial ruptures allowing the chemicals to
eact producing light of blue-white color for duration of 10 min  in
 wavelength range of 430–580 nm.
The patient was asked to rinse the mouth with 30 ml  of 1%
cetic acid solution for 1 min  following which the capsule was
ctivated and assembled into the retractor. The acetic acid rinse
erved to remove the debris and glycoprotein barrier from the
ucosa to enhance the penetration of light. The soft tissues were
ried and examination was repeated by the same observer under
hemiluminescent illumination after dimming the room lights. The
esions were again photographed and the presence of an “aceto-
hite” lesion was deﬁned as a “positive” test, while the absence of
uch ﬁnding was deﬁned as a “negative” test.
Depending on the size of the lesion and results of chemi-
uminescent examination, incisional or excisional biopsy of the
esion was done by the same examiner. The histopathological
xamination was done by a single pathologist to evaluate the dys-
lastic changes and grade them according to the World Health
rganization criteria [8]. The presence of dysplasia was  considered
s “positive test” and absence of it was considered as “negative test”
Figs. 1–3).
The  collected data were entered through the SPSS version 18
oftware (SAS Inc., Cary, NC, USA). Sensitivity, speciﬁcity, positive
redictive value, negative predictive value, and accuracy of Vizilite
ere calculated.
The  chemiluminescence results were compared with
istopathological results using Chi-Square test with p-value
et as ≤0.05.
.  Results
The demographic data of 50 patients enrolled in the study are
iven in Table 1. Out of 50 lesions examined, 37 (74%) were cate-
orized as homogenous leukoplakia and 13 (26%) were categorized
s non-homogenous leukoplakia (speckled leukoplakia).
On histopathological examination of these 50 lesions, 64% were
iagnosed with dysplasia. Of these, 42% were categorized as mild
ysplasia, 14% moderate dysplasia, 4% severe dysplasia, and 4% car-
inoma in situ.
On  Vizilite examination, 38 lesions (76%) showed aceto-white
ppearance. Among these 30 lesions (78.9%) were identiﬁed
s dysplastic on histopathological examination. Out of the 12
esions that were identiﬁed as negative by the chemiluminescence
est, 2 lesions (16%) were identiﬁed as positive for dyspla-
ia. The sensitivity of chemiluminescence test was  93.75% andFig. 1. (a) Non-homogenous leukoplakia on right retrocommisure. (b) Negative
result  on Vizilite examination.
speciﬁcity was 55.56%. The positive predictive value was 78.95%
and negative predictive value was 83.3%. The overall accuracy of
chemiluminescence was 80% (Table 2).
A statistically signiﬁcant association was observed between
the chemiluminescence results and histopathology results
(2 = 15.354) at the set p-value (p ≤ 0.05).
4.  Discussion
The 50 leukoplakias included in the study were mainly seen
on the buccal mucosa in the patient age group 20–40 years. But
the severity of dysplasia is more in the age group 60–80 years.
In non-homogenous leukoplakias, 15% of cases showed no dyspla-
sia whereas in homogenous leukoplakia 43% of cases showed no
dysplasia. In both types of leukoplakia, the majority of the cases
showed mild dysplasia.
In  chemiluminescent examination, the number of false positives
was 8 (21.1%) (Table 2). This is similar to the result obtained by
Ram and Siar [3]. The high false positive rate was also conﬁrmed by
58 A. Chaudhry, M.  M / Oral Science International 11 (2014) 56–59
Table  1
Demographic data.
n = 50 (%)
Gender
Male 37 (74%)
Female 13 (26%)
Age group (years)
20–40  24 (48%)
40–60 20 (40%)
60–80 4 (8%)
80–100 2 (4%)
Site
Buccal mucosa 41 (82%)
Commisure 5 (10%)
Labial mucosa 1 (2%)
Tongue 1 (2%)
Palate 1 (2%)
Habit
Smokeless tobacco (including betel nut) 30 (60%)
Smoking tobacco 16 (32%)
Both 4 (8%)
Fig. 2. (a) Homogenous leukoplakia on lower labial mucosa. (b) Positive result on
Vizilite examination.
Table 2
Chemiluminescence results compared to histopathology.
Chemiluminescence Histopathology Sensitivity
Positive Negative Total
Positive 30 8 38
93.75 Negative 2 10 12
Total 32 18 50
PPV, positive predictive value; NPV, negative predictive value.Fig. 3. (a) Non-homogenous leukoplakia on right retrocommisure. (b) Positive result
on Vizilite examination.
Huber et al. [9] and Farah and McCullough [10]. The number of false
negatives was 2 (16.7%). The degree of dysplasia in these 2 lesions
was of mild and moderate grade. This is different from other studies
by Ram and Siar [3], Farah and McCullough [10], Epstein et al. [11]
where the number of false negatives was  0%. This increased number
of false negatives even in clinically suspicious leukoplakia is highly
doubtful of the usefulness of this adjunct in comparison to biopsy.
 (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
55.56 78.95 83.33 80
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Out of 37 homogenous leukoplakias, chemiluminescence was
ositive in 26 (70.2%) lesions, and all of the 13 nonhomogenous
eukoplakias were tested as positive by chemiluminescence.
Out of 26 chemiluminescent positive homogenous leukoplakias,
0 lesions (77%) were positive for dysplasia with mild and moderate
rades.
Out of 13 nonhomogenous leukoplakias, 11 lesions (84.6%) were
ound to be dysplastic with higher grades such as severe dysplasia
nd carcinoma in situ.
This  shows the ability of chemiluminescence to detect dys-
lasias accurately. In our study speckled leukoplakias were
etected more accurately in contrast to the results of other studies
here Vizilite was able to detect white patches more accurately
han red patches [12,13]. One possible reason for this could be
ncreased penetration of light through the atrophic areas of non-
omogenous leukoplakia.
One  of the components of chemiluminescent examination is
cetic acid pre-rinse. It is mainly done to remove the debris and gly-
oprotein layer for enhanced penetration and reﬂection of light. But
cetic acid is also known to cause cellular dehydration and protein
oagulation that reduces the transparency of the epithelium [14].
his could be one of the reasons for the aceto-white appearance of
he white lesions.
The  various studies that have been done to evaluate Vizilite have
hown conﬂicting results.
Multiple  studies have shown that chemiluminescence increases
he brightness and margins of mucosal lesions and thus assist in
dentiﬁcation of mucosal lesions not considered under traditional
isual examination [3,11]. In contrast, Oh et al. [15] showed that
o additional lesions were detected with chemiluminescent light.
oreover, chemiluminescent light produced reﬂections that made
isualization more difﬁcult and thus was not beneﬁcial.
There are many limitations associated with the use of Vizilite.
hese include high cost per capsule, high number of false positives
nd false negatives which may  lead to overtreatment or no treat-
ent, ultimately being harmful to the patient rather than being
seful. The interpretation of aceto-white appearance is subjective
nd it may  vary from examiner to examiner. This is proved by the
ontrasting results of the various studies done. Moreover, the visu-
lization of aceto-whitening may  be inﬂuenced by the saliva. Acetic
cid pre-rinse may  stimulate the salivation which interferes with
ucosal reﬂectance rendering it difﬁcult to limit the lesion bound-
ries [13]. This visualization adjunct gives information only about
he horizontal extent of the lesion (one dimension). The depth of
he lesion which is more important in predicting the malignant
ehavior cannot be assessed through this modality.
The limitation of the present study was that only clinically obvi-
us lesions of leukoplakia which can be adequately diagnosed using
isual examination and palpation were included. This was  done
o determine the characteristics of clinically obvious leukoplakia
nder chemiluminescent illumination and to test its efﬁcacy in
etecting dysplastic lesions.
The  evaluation of clinically inconspicuous lesions by this tech-
ique was not assessed in the present study. So, further studies are
[
[ternational 11 (2014) 56–59 59
required to assess the efﬁcacy of this modality in detecting incon-
spicuous lesions in patients with high-risk habits or in previously
treated squamous cell carcinomas to detect secondary tumors.
Although  chemiluminescence has been promoted as a valu-
able adjunct in the early detection of potentially malignant oral
disorders, there is no evidence that use of it will negate further
evaluation of a clinically suspicious lesion.
So further studies with well deﬁned objectives, larger sample
sizes, and with histopathological conﬁrmation are required.
5.  Conclusion
Chemiluminescence is an easy, safe, minimal time consuming,
and noninvasive technique which has only adjunctive utility in the
diagnosis of leukoplakia. The false negative test even in clinically
diagnosed lesions would argue against its use as a prime diagnostic
modality as compared to biopsy. Moreover, the interpretation of the
aceto-white appearance is subjective and is inﬂuenced by external
factors such as saliva. Therefore, well deﬁned criteria for aceto-
white appearance should be established.
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